ERY-TAB 500 mg/1 (Erythromycin TABLET, DELAYED RELEASE) 500 mg/1

ERY-TAB 500 mg is an oral delayed-release erythromycin tablet used for bacterial infections. This antibiotic helps fight bacterial growth, often prescribed for respiratory or skin conditions.

Strength

500 mg/1

Pack Size

30 TABLET, DELAYED RELEASE in 1 BOTTLE (24338-126-03)

Manufacturer / TM Owner

Arbor Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ERY-TAB 500 mg is an erythromycin antibiotic used to treat bacterial infections. Common uses include respiratory infections like bronchitis or pneumonia, as well as skin infections. Erythromycin works by stopping bacterial growth, helping the body fight off infections. It is often prescribed when penicillin is not an option.

Side Effects

ERY-TAB 500 mg may cause common side effects such as nausea, vomiting, or stomach upset. Some users report diarrhea or mild skin rashes. These effects vary and are not experienced by everyone. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

ERY-TAB 500 mg should be handled with care. Store at room temperature, away from moisture and heat. Keep out of reach of children. Do not use if allergic to erythromycin or similar antibiotics. Inform your healthcare provider of any existing medical conditions.

Avoid Interactions

ERY-TAB 500 mg may interact with other medications, including certain antibiotics, antifungals, and heart rhythm medications. Alcohol should be avoided as it may worsen side effects. Always inform your healthcare provider of all medications you are taking to avoid potential interactions.

Frequently Asked Questions

ERY-TAB 500 mg is used to treat bacterial infections, often respiratory or skin-related. It is an erythromycin antibiotic that stops bacterial growth.

ERY-TAB 500 mg is an oral delayed-release tablet. Follow your healthcare provider's instructions for proper administration.

Common side effects may include nausea, vomiting, stomach upset, diarrhea, or mild skin rashes. Not everyone experiences these effects.

ERY-TAB 500 mg may interact with other medications. Always inform your healthcare provider of all medications you are taking.

ERY-TAB 500 mg should be kept out of reach of children. Consult a healthcare provider for advice on use in children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.